Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

ccfDNA In the Lab: Optimizing Purification for Sequencing


ccfDNA Webinar Series: The Basics and Beyond
Part 3 - ccfDNA In the Lab: Optimizing Purification for Sequencing

Circulating Cell-free DNA can be used to monitor tumor burden and monitor disease progress. In this webinar, Dr. Gulley discusses variables important to isolating high-quality ccfDNA from plasma samples including anticoagulant, plasma volume and storage length and conditions.

Have you seen the first 2 parts of the series?



Margaret Gulley, MD
Professor and Director of Molecular Pathology
University of North Carolina-Chapel Hill

Margaret L. Gulley MD is professor and Director of Molecular Pathology in the Department of Pathology and Laboratory Medicine at University of North Carolina at Chapel Hill, USA. She provides laboratory services to patients with cancer, heritable disease, infectious disease, or transplant. Dr. Gulley’s research on virus-related malignancy seeks to validate novel molecular assays that add value for disease classification and monitoring. Work with professional societies aims to promote high quality molecular services in clinical laboratories.

We love to talk science.

Sign up to receive monthly invitations to our webinars.

Sign Up